EMA Adopts Guideline on Treatments for Autism

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency adopted a guideline for sponsors developing new products for autism spectrum disorder, providing recommendations on diagnostic criteria, target populations and clinical trial design.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor